Huang YJ, Chang CH, Lee SW, Tung CF, et al. Higher Off-Therapy Relapse Risk with Tenofovir Alafenamide than Entecavir in Non-cirrhotic HBeAg-Negative Chronic Hepatitis B: Insights from End-of-Treatment qHBsAg Stratification. Dig Dis Sci 2026 Aug 18. doi: 10.1007/s10620-026-10188.
PMID: 42613484